Status:
TERMINATED
AMP as a Better Delivery System of Adenosine
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
Ischemia
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
Adenosine and AMP are substances normally present in the body. Adenosine is also given for the treatment of some heart rhythm problems and may be used to reduce heart damage during heart attacks. The ...
Eligibility Criteria
Inclusion
- Healthy volunteers
- Age 18-65
- Non smokers
Exclusion
- Smokers
- Any chronic disease
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00179010
Start Date
October 1 2003
End Date
January 1 2017
Last Update
May 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232